Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.

Volltext-Artikel, E-Books und Literaturhinweise aus dem EBSCO Discovery Service

"Artikel & mehr" berücksichtigt nur einen Teil der für die Bibliothek der Frankfurt UAS verfügbaren Datenbanken. Zur Übersicht in DBIS

Ergebnis verändern

einschränken: Volltextzugriff; Academic (peer-reviewed) journals
erweitern: Auch Volltexte der Artikel durchsuchen; Verwandte Themen suchen

Publikationstyp

Thema

erschienen in

Verlag

Geographic terms

Sprache

Datenbank

Erscheinungsjahr

Von:

Bis:

Treffer 1 - 25 von 147, Suchdauer: 0.95s

12 3 4 5 6 weiter »

1
Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib

von Coombes, RC ; Howell, S ; Lord, SR ; et al.
- View full text via BASE
Merkliste

2
Zanubrutinib in patients with treatment‐naïve or relapsed/refractory Waldenström macroglobulinemia: An expanded‐access study of 50 patients in the United States

von Jorge J Castillo ; Edwin C Kingsley ; Mohit Narang ; et al.

eJHaem, Vol 4, Iss 1, Pp 301-304 (2023)

Schlagworte: BTK inhibitor; Waldenström macroglobulinemia; zanubrutinib; Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

3
Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.

von Coombes, RC ; Howell, S ; Lord, SR ; et al.

1.

Schlagworte: England
- View full text via BASE
Merkliste

4
P1156: MAGNIFY PHASE 3B STUDY OF LENALIDOMIDE + RITUXIMAB (R2) FOLLOWED BY MAINTENANCE IN RELAPSED/REFRACTORY INDOLENT NON-HODGKIN LYMPHOMA: COMPLETE INDUCTION PHASE ANALYSIS

von Lansigan, F. ; Andorsky, D. J. ; Coleman, M. ; et al.

HemaSphere ; volume 6, page 1043-1044 ; ISSN 2572-9241
- View full text via BASE
Merkliste

5
P1089: BRENTUXIMAB VEDOTIN, NIVOLUMAB, DOXORUBICIN, AND DACARBAZINE (AN+AD) FOR ADVANCED STAGE CLASSIC HODGKIN LYMPHOMA: PRELIMINARY SAFETY AND EFFICACY RESULTS FROM THE PHASE 2 STUDY (SGN35 027 PART B)

von Lee, H. ; Flinn, I. W. ; Melear, J. ; et al.

HemaSphere ; volume 6, page 979-980 ; ISSN 2572-9241
- View full text via BASE
Merkliste

6
P1160: RESULTS OF A PHASE 2 EXPANDED ACCESS STUDY OF ZANUBRUTINIB IN PATIENTS WITH WALDENSTRÖM MACROGLOBULINEMIA

von Castillo, J. J. ; Kingsley, E. C. ; Narang, M. ; et al.

HemaSphere ; volume 6, page 1047-1048 ; ISSN 2572-9241
- View full text via BASE
Merkliste

7
INDUCTION R2 FOLLOWED BY MAINTENANCE IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA: INTERIM ANALYSIS FROM THE PHASE 3B MAGNIFY STUDY

von JP Sharman ; JM Melear ; A Yacoub ; et al.

Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S73- (2021)

Schlagworte: Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

8
PATIENTS WITH RELAPSED/REFRACTORY MARGINAL ZONE LYMPHOMA IN THE MAGNIFY PHASE 3B INTERIM ANALYSIS OF INDUCTION R2 FOLLOWED BY MAINTENANCE

von M Coleman ; DJ Andorsky ; A Yacoub ; et al.

Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S98- (2021)

Schlagworte: Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

9
INDUCTION R 2 FOLLOWED BY MAINTENANCE IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA: INTERIM ANALYSIS FROM THE PHASE 3B MAGNIFY STUDY

von Sharman, J. P. ; Melear, J. M. ; Yacoub, A. ; et al.

Hematological Oncology ; volume 39, issue S2 ; ISSN 0278-0232 1099-1069
- View full text via BASE
Merkliste

10
Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial

von Mateos M. -V. ; Blacklock H. ; Schjesvold F. ; et al.
- View full text via BASE
Merkliste

11
PS1071 PRELIMINARY RESULTS OF A PHASE 1 DOSE ESCALATION STUDY OF THE FIRST-IN-CLASS ANTI-CD74 ANTIBODY DRUG CONJUGATE (ADC), STRO-001, IN PATIENTS WITH ADVANCED B-CELL MALIGNANCIES

von Shah, N. ; Krishnan, A. ; Burke, J. ; et al.

HemaSphere ; volume 3, issue S1, page 485 ; ISSN 2572-9241
- View full text via BASE
Merkliste

12
A phase Ia/b first-in-human, open-label, dose-escalation, safety, PK and PD study of TP-0903 in solid tumours

von Sarantopoulos, J. ; Fotopoulos, G. ; Tsai, F Y -C ; et al.

Annals of Oncology ; volume 30, page v172 ; ISSN 0923-7534
- View full text via BASE
Merkliste

13
Dieses Ergebnis aus Science Citation Index Expanded kann Gästen nicht angezeigt werden.
Login für vollen Zugriff.
- Zur Referenz in Web of Science
Merkliste

14
Phase I dose expansion data for M6620 (formerly VX-970), a first-in-class ATR inhibitor, combined with gemcitabine (Gem) in patients (pts) with advanced non-small cell lung cancer (NSCLC)

von Plummer, R. ; Cook, N. ; Arkenau, T. ; et al.

Annals of Oncology ; volume 29, page viii519 ; ISSN 0923-7534
- View full text via BASE
Merkliste

15
The AXL inhibitor, TP-0903, reverses EMT and shows activity in non-small cell lung cancer preclinical models

von Joe, R. ; Matsumura, Y. ; Siddiqui, A. ; et al.

European Journal of Cancer ; volume 174, page S57-S58 ; ISSN 0959-8049
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

16
A phase 1b study evaluating the safety and preliminary efficacy of berzosertib in combination with gemcitabine in patients with advanced non-small cell lung cancer

von Plummer, R. ; Dean, Emma J ; Arkenau, H. T. ; et al.
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

17
Prospective Observational Study of Pazopanib in Patients with Advanced Renal Cell Carcinoma (PRINCIPAL Study)

von Schmidinger M. ; Bamias A. ; Procopio G. ; et al.

Schlagworte: Observational; Pazopanib; Real-world; Renal cell carcinoma; Tyrosine kinase inhibitor; Adult; Aged; 80 and over; Angiogenesis Inhibitor; Carcinoma; Renal Cell; Female; Follow-Up Studie; Human; Indazole; Kidney Neoplasm; Male; Middle Aged; Prognosi; Prospective Studie; Pyrimidine; Quality of Life; Sulfonamide; Survival Rate; Treatment Outcome; Young Adult
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

18
Crystal-Chemical Changes in an Oxidative Weathering Front in a Georgia Kaolin Deposit

von Schroeder, Paul A. ; Pruett, Robert J. ; Melear, Nathan D.

Clays and Clay Minerals. 52(2):211-220
- Zum Volltext (via ReDI)
Merkliste

19
Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib

von Coombes, R. C. ; Howell, S. ; Lord, S. R. ; et al.
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

20
INTERIM ANALYSIS OF PHASE IIIB MAGNIFY STUDY OF INDUCTION R 2 FOLLOWED BY MAINTENANCE IN PATIENTS WITH RELAPSED/REFRACTORY INDOLENT NON‐HODGKIN LYMPHOMA

von Sharman, J. ; Coleman, M. ; Yacoub, A. ; et al.

Hematological Oncology ; volume 37, issue S2, page 115-116 ; ISSN 0278-0232 1099-1069
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

21
Prospective Observational Study of Pazopanib in Patients with Advanced Renal Cell Carcinoma (PRINCIPAL Study)

von Schmidinger, M. ; Bamias, A. ; Procopio, G. ; et al.

Schlagworte: scientific_publication_article; Scientific publication - Journal Article
- Zum Volltext über OAIster
Merkliste

22
536MO A phase I, first-in-human, safety, pharmacokinetic, and pharmacodynamic study of oral dubermatinib (TP-0903) in patients with advanced solid tumours

von Adjei, A.A. ; Beg, M. ; Melear, J. ; et al.

In Annals of Oncology September 2020 31 Supplement 4:S469-S469
- View full text via DOI
Merkliste

23
Wastewater Treatment.

von Zoltek, J. ; Melear, E. L.

Journal of the Water Pollution Control Federation. Jun78 50(6):1066-1075.

Schlagworte: Bibliographies; Chemical Analysis; Environmental Education; Literature Reviews; Physical Sciences; Pollution; Postsecondary Education; Research Reviews (Publications); Waste Disposal; Water Pollution
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

24
A phase 1b study evaluating the safety and preliminary efficacy of berzosertib in combination with gemcitabine in patients with advanced non-small cell lung cancer

von Plummer R ; Dean E ; Arkenau H-T ; et al.

Lung Cancer, January 2022
- View full text via BASE
Merkliste

25
A phase 1b study evaluating the safety and preliminary efficacy of berzosertib in combination with gemcitabine in patients with advanced non-small cell lung cancer

von Plummer, R ; Dean, E ; Arkenau, HT ; et al.

Lung Cancer , 163 pp. 19-26. (2022)

Schlagworte: Berzosertib; Gemcitabine; Non-small cell lung cancer; ATR inhibitor; DNA-damage response
- View full text via BASE
Merkliste

12 3 4 5 6 weiter »

Sie haben nicht gefunden, wonach Sie gesucht haben? Diese Services können Ihnen weiterhelfen.
Hilfe & Kontakt ǀ Fernleihe | Hilfe zur Fernleihe ǀ Literaturvorschlag| Literaturvorschlag